Steveng Deeks News Today

Researchers at UCSF have discovered an unexpectedly high rate of COVID rebound following treatment with Paxlovid. A group of scientists from the University of California, San Francisco, discovered that Paxlovid (Nirmatrelvir-ritonavir) was ineffective in lowering the chances of vaccinated, non-hosp

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, no

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, no

Components of the SARS-CoV-2 virus remain in the gut of some long COVID patients, causing persistent inflammation, vagus nerve dysfunction, and neurological symptoms. Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-1

The cells of ‘super dodgers’ know SARS-CoV-2 as the enemy thanks to seasonal colds.

Researchers are looking to "understand the epidemiology and pathogenesis of chronic symptoms, and identify more effective ways to manage, treat, and potentially cure these illnesses."

Women who embrace six healthy lifestyle factors can cut their long COVID risk in half, per a new study led by Harvard T.H. Chan School of Public Health. Heres what

Women who embrace six healthy lifestyle factors can cut their long COVID risk in half, per a new study led by Harvard T.H. Chan School of Public Health. Here's what to know and why.

A new study points to another persistent effect of COVID-19, identified months after infection: reduced exercise capacity.

/PRNewswire/ -- Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all...